AnalystsLes SulewskiLes Sulewski's Stock Forecasts
AnalystsLes Sulewski
Sectors:
Industries:
Analyst Ranking
Bottom 10%
#4657 out of 5116 analysts
Average Return
-15.66%
Win Rate
46%6 out of 13
Risk vs Reward
Poor
Good
Les Sulewski's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Teva Pharmaceutical Industries LtdTEVA | +48.15% | $18.15 | $26.89 | 2025-05-28 - 2025-11-28 | Strong Buy |
Amneal Pharmaceuticals IncAMRX | +20.84% | $8.59 | $10.38 | 2024-10-02 - 2025-10-01 | Strong Buy |
Amneal Pharmaceuticals IncAMRX | +17.24% | $7.54 | $8.84 | 2024-08-12 - 2025-08-11 | Strong Buy |
Amneal Pharmaceuticals IncAMRX | +13.38% | $6.65 | $7.54 | 2024-05-06 - 2025-05-05 | Strong Buy |
Collegium Pharmaceutical IncCOLL | +10.35% | $42.30 | $46.68 | 2025-11-07 - 2025-11-28 | Strong Buy |
Les Sulewski Analyst Color
Get additional color on Les Sulewski's coverage of popular stocks
Les Sulewski's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Pacira Biosciences IncPCRX | 7 | Strong Buy | $28.00 | +18.80% | Maintains | 25 days ago |
Collegium Pharmaceutical IncCOLL | 3 | Strong Buy | $48.00 | +2.83% | Maintains | 25 days ago |
Teva Pharmaceutical Industries LtdTEVA | 1 | Strong Buy | $25.00 | -7.03% | Initiates Coverage On | 6 months ago |
Amneal Pharmaceuticals IncAMRX | 3 | Strong Buy | $12.00 | N/A | Maintains | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.